27 Apr Fertomid-50 Tablets (Clomiphene Citrate 50 mg)
|
Company name & Address |
Registration number |
Batch number(s) |
Expiry date |
Pack size |
First distributed |
Re-call Classification |
Recall date |
Published date |
| Cipla Medpro (Pty) Ltd
Parc du Cap, Building 9, Mispel Street, Bellville, 7530 |
31/18.8/0625 | GH21051 | October 2025
|
10 tablets | 08 March 2023 | Class II Type C | 03 March 2025 | 10 March 2025 |
Brief description of the problem (reason for recall)
An out-of-specification result for related substances observed during stability testing of batch GH21051.
Advice for health professionals and distributors
We request that you refrain from selling or dispensing Fertomid-50 Tablets, Batch No. GH21051. Please return all remaining stock to your supplying warehouse or distributor with immediate effect. Cipla Medpro (Pty) Ltd will collect all your stock which will be credited / replaced.
Proposed action taken and its urgency: A SAHPRA approved recall letter was distributed to all distribution points and the recall process was initiated.
Reporting side effects
Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.